Insys Therapeutics (INSY) Comments on Unsealing of Previously Filed Qui Tam Complaints and Recaps Transformation Efforts

May 15, 2018 12:23 PM
INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Litigation

Next Articles